Other
Revenue
Regeneron Pharmaceuticals Revenue decreased by 7.2% to $3.61B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.0%, from $3.03B to $3.61B. Over 4 years (FY 2021 to FY 2025), Revenue shows a downward trend with a -2.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOther
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026Apr 29, 2026
How to read this metric
An increase indicates growth in market share or higher demand, while a decrease may signal market saturation or competitive pressure.
Detailed definition
Represents the total consideration received from customers for the sale of goods or services, excluding any sales-relate...
Peer comparison
Standard across all public companies; comparable to 'Net Sales' or 'Total Revenue' at peer distributors.
Metric ID:
other_revenue_from_contract_with_customer_excluding_asse_0d5b70Historical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.14B | $3.45B | $4.95B | $2.97B | $2.86B | $2.94B | $3.41B | $3.16B | $3.16B | $3.36B | $3.43B | $3.15B | $3.55B | $3.72B | $3.79B | $3.03B | $3.68B | $3.75B | $3.88B | $3.61B |
| QoQ Change | — | -32.8% | +43.4% | -40.1% | -3.6% | +2.8% | +16.3% | -7.4% | -0.1% | +6.5% | +2.1% | -8.4% | +12.8% | +4.9% | +1.8% | -20.1% | +21.4% | +2.1% | +3.5% | -7.2% |
| YoY Change | — | — | — | — | -44.4% | -15.0% | -31.0% | +6.6% | +10.5% | +14.5% | +0.6% | -0.5% | +12.3% | +10.6% | +10.3% | -3.7% | +3.6% | +0.9% | +2.5% | +19.0% |
Range$2.86B – $5.14B
CAGR-7.2%
Avg YoY Growth-0.2%
Median YoY Growth+3.1%
Revenue at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's revenue?
- Regeneron Pharmaceuticals (REGN) reported revenue of $3.61B in Q1 2026.
- How has Regeneron Pharmaceuticals's revenue changed year-over-year?
- Regeneron Pharmaceuticals's revenue increased by 19.0% year-over-year, from $3.03B to $3.61B.
- What is the long-term trend for Regeneron Pharmaceuticals's revenue?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's revenue has grown at a -2.8% compound annual growth rate (CAGR), from $16.07B to $14.34B.
- What does revenue mean?
- The total amount of money earned from selling products or services to customers before taxes.